Dr. Laura Muinelo is the Head of the Liquid Biopsy Analysis Unit at Health Research Institute of Santiago de Compostela (IDIS) and co-coordinator of the Liquid Biopsy working group of CIBERONC. The Unit is specialized in the study of circulating biomarkers, mainly CTCs and ctDNA, as a tool to characterize tumors and develop a more personalized oncology. Her research is focused on the validation and application of liquid biopsy in the context of MRD detection, treatment selection and monitoring for different solid tumours, and specially for endometrial cancer.
Tuesday, 17 June 2025
| Time |
Session |
|
|
13:30
14:15
|
-
Introduction
-
Role of cfDNA and ctDNA to improve the risk stratification and the disease follow-up in patients with endometrial cancer
-
Detection rate for ESR1 mutations is higher in CTC-derived genomic DNA than in paired plasma cell-free DNA samples as revealed by ddPCR
-
Questions and Answers
Auditorium 8
|
